Jun J. Mao (@junmaomd) 's Twitter Profile
Jun J. Mao

@junmaomd

Chief of MSK Integrative Medicine Service, physician, researcher. Views are my own.

ID: 950546284749897729

linkhttps://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine calendar_today09-01-2018 01:54:29

2,2K Tweet

1,1K Takipçi

490 Takip Edilen

Eric Topol (@erictopol) 's Twitter Profile Photo

The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial NEJM #ASCO25 nejm.org/doi/full/10.10…

The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial <a href="/NEJM/">NEJM</a> #ASCO25 
nejm.org/doi/full/10.10…
Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

Plenary session alert ➡️ MSK gastrointestinal oncologist Yelena Y. Janjigian MD will share results from "Event-free survival (EFS) in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy (FLOT) in resectable

Plenary session alert ➡️ MSK gastrointestinal oncologist <a href="/YJanjigianMD/">Yelena Y. Janjigian MD</a> will share results from "Event-free survival (EFS) in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy (FLOT) in resectable
Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

New results from the global, randomized, phase 3 #MATTERHORN study, led by Yelena Y. Janjigian MD, show that perioperative durvalumab plus 5-FU, leucovorin, oxaliplatin, and docetaxel (#FLOT) yields superior event-free survival over FLOT plus placebo in patients with resectable,

Nicolas Hart (@drnicolashart) 's Twitter Profile Photo

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival: “For every 16 people, exercise prevents 1 person from recurrent/new cancer” “For every 14 people, exercise prevents 1 person from dying”

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival:

“For every 16 people, exercise prevents 1 person from recurrent/new cancer”

“For every 14 people, exercise prevents 1 person from dying”
Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

If this were a pill, we’d call it revolutionary. It would headline plenaries, get FDA priority review, and cost $10,000 a month. Instead—it’s structured exercise. 🆕 NEJM June 2025 | CHALLENGE Trial Stage II–III colon cancer patients post-chemo (n=889) 📦 RCT of 3 years of

If this were a pill, we’d call it revolutionary.
It would headline plenaries, get FDA priority review, and cost $10,000 a month.

Instead—it’s structured exercise.

🆕 NEJM June 2025 | CHALLENGE Trial
Stage II–III colon cancer patients post-chemo (n=889)
📦 RCT of 3 years of
Jun J. Mao (@junmaomd) 's Twitter Profile Photo

Such powerful data! Getting patients to initiate & persist with exercise may not be easy but should definitely be emphasized in cancer care & paid for.

Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

MSK integrative medicine specialist Kevin Liou presented research about #musictherapy versus cognitive behavioral therapy for #anxiety in #cancer survivors today at #ASCO25. Swipe below for a brief recap. ASCO

MSK integrative medicine specialist <a href="/KevinLiouMD/">Kevin Liou</a> presented research about #musictherapy versus cognitive behavioral therapy for #anxiety in #cancer survivors today at #ASCO25. Swipe below for a brief recap. <a href="/ASCO/">ASCO</a>
Cristiane D Bergerot (@crisbergerot) 's Twitter Profile Photo

🧠💬 Symptom Science & Palliative Care at #ASCO25: From CBT & light therapy for insomnia to duloxetine for CIPN, TCM for fatigue, SIC pathways, & cognitive outcomes in ICI tx—cutting-edge trials reshaping how we care for patients Don’t miss this powerhouse panel! Nicole L. Stout DPT, FAPTA

🧠💬 Symptom Science &amp; Palliative Care at #ASCO25:

From CBT &amp; light therapy for insomnia to duloxetine for CIPN, TCM for fatigue, SIC pathways, &amp; cognitive outcomes in ICI tx—cutting-edge trials reshaping how we care for patients

Don’t miss this powerhouse panel! <a href="/NicoleStoutPT/">Nicole L. Stout DPT, FAPTA</a>
HemOnc Today (@hemonctoday) 's Twitter Profile Photo

🎵#ASCO25 data found #MusicTherapy as effective as cognitive behavioral therapy for reducing anxiety in #cancer survivors Next steps? Whether personal characteristics “can predict better response to one therapy🆚another.” Kevin Liou Memorial Sloan Kettering Cancer Center healio.com/news/hematolog…

Jun J. Mao (@junmaomd) 's Twitter Profile Photo

Our RCT should virtual integrative medicine not only improved symptoms of fatigue & depression but also reduced patients’ risk to be hospitalized while receiving active cancer treatment.

Ryan Nipp, MD, MPH, FASCO (@ryannipp) 's Twitter Profile Photo

Exercise therapy and self-management support for individuals with multimorbidity: a randomized and controlled trial. nature.com/articles/s4159… nature Nature Portfolio Nature Medicine #Exercise #Geriatrics #MedTwitter

Exercise therapy and self-management support for individuals with multimorbidity: a randomized and controlled trial.

nature.com/articles/s4159…

<a href="/Nature/">nature</a> <a href="/NaturePortfolio/">Nature Portfolio</a> <a href="/NatureMedicine/">Nature Medicine</a> 
#Exercise #Geriatrics #MedTwitter
Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

MSK researchers are advancing the standard of care for treating head and neck cancers, including #thyroidcancer. Recent work highlights progress in areas such as active surveillance, identification of mutation profiles, #redifferentiation therapy, and more:

MSK researchers are advancing the standard of care for treating head and neck cancers, including #thyroidcancer. Recent work highlights progress in areas such as active surveillance, identification of mutation profiles, #redifferentiation therapy, and more:
Ryan Nipp, MD, MPH, FASCO (@ryannipp) 's Twitter Profile Photo

Role of a Designated Pharmacist in Reducing Adverse Drug Reaction Rates and Preventing Potential Medication Errors in Hematology-Oncology: A Randomized Controlled Trial. ascopubs.org/doi/10.1200/OP… ASCO Journal of Clinical Oncology JCO Oncology Practice #SuppOnc #CancerResearch #CancerCare

Role of a Designated Pharmacist in Reducing Adverse Drug Reaction Rates and Preventing Potential Medication Errors in Hematology-Oncology: A Randomized Controlled Trial. 

ascopubs.org/doi/10.1200/OP…

<a href="/ASCO/">ASCO</a> <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> 
#SuppOnc #CancerResearch #CancerCare
Ryan Nipp, MD, MPH, FASCO (@ryannipp) 's Twitter Profile Photo

Daily Patient-Reported Symptoms as Predictors of Unplanned Health Care Encounters During Chemotherapy: Longitudinal Observational Study. ascopubs.org/doi/10.1200/OP… JCO Oncology Practice Journal of Clinical Oncology ASCO #PallOnc #SuppOnc Jeffrey peppercorn MD

Daily Patient-Reported Symptoms as Predictors of Unplanned Health Care Encounters During Chemotherapy: Longitudinal Observational Study. 

ascopubs.org/doi/10.1200/OP…

<a href="/JCOOP_ASCO/">JCO Oncology Practice</a> <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> <a href="/ASCO/">ASCO</a> 
#PallOnc #SuppOnc 
<a href="/EthicsdoctorP/">Jeffrey peppercorn MD</a>
Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

According to a study co-led by researchers at MSK and published in Nature Medicine, a new vaccine shows encouraging early results as a potential ready-made treatment for patients with pancreatic or colorectal cancer. Unlike individualized cancer vaccines, which are tailored to

According to a study co-led by researchers at MSK and published in <a href="/NatureMedicine/">Nature Medicine</a>, a new vaccine shows encouraging early results as a potential ready-made treatment for patients with pancreatic or colorectal cancer.

Unlike individualized cancer vaccines, which are tailored to
Jun J. Mao (@junmaomd) 's Twitter Profile Photo

Social media means to be engaging, even in scientific meetings. I love seeing selfies of my colleagues. Research & clinical work are hard enough. Can we allow people to be humans & have a sense of humor?

Jun J. Mao (@junmaomd) 's Twitter Profile Photo

Really honored to be part of this complimentary virtual event to connect with our global community to learn & share strategies that reduce the suffering of cancer. Integrative medicine can help patients & families gain sense of control, reduce symptoms & improve QOL.